| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.043 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.037 | 0.8 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |